Rishi Gupta insider trades: Enliven Therapeutics (ELVN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rishi reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 16, 2024 | ELVN | ↓ Sell | 1,033,300 | $22.14 | $22.9M | Indirect | May 20, 2024 (4d) |
| Jul 20, 2023 | TSBX | ↑ Buy | 416,666 | $12.00 | $5.0M | Indirect | Jul 24, 2023 (4d) |
| May 15, 2023 | VRNA | ↓ Sell | 482,913 | $20.58 | $9.9M | Indirect | May 15, 2023 (0d) |
| Dec 23, 2022 | VRNA | ↓ Sell | 6,139,864 | $22.15 | $136.0M | Indirect | Dec 27, 2022 (4d) |
| Oct 27, 2015 | DMTX | ↑ Buy | 200,000 | $13.00 | $2.6M | Indirect | Oct 29, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELVN insiders
Open-market trades in the last 12 months
About Rishi Gupta's insider trades
Rishi Gupta is an insider at Enliven Therapeutics (ELVN). Since Oct 27, 2015, Rishi has reported 2 open-market purchases worth $7.6M and 3 sales worth $168.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), conversions (2 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.